A Phase II Trial of Celecoxib in Patients With IPMN.

Trial Profile

A Phase II Trial of Celecoxib in Patients With IPMN.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2016

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2011 Planned end date changed from 1 Sep 2016 to 1 Sep 2021 as reported by ClinicalTrials.gov.
    • 12 Jul 2010 Planned end date changed from 1 Sep 2014 to 1 Sep 2016 as reported by ClinicalTrials.gov.
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top